Retinitis Pigmentosa
Description
Retinitis pigmentosa (RP) is an inherited retinal dystrophy leading to progressive loss of the photoreceptors and retinal pigment epithelium and resulting in blindness usually after several decades.
Genes related to Retinitis Pigmentosa
- RPGR
- BEST1
- IMPG2
- PRPH2
- POMGNT1
- BBS2
- ARL6
- IFT172
- TTC8
- C8orf37
- KLHL7
- RLBP1
- PROM1
- CRX
- CDHR1
- SEMA4A
- ABCA4
- RHO
- PDE6B
- SAG
- ZNF408
- NR2E3
- IFT140
- ARL3
- AHI1
- CRB1
- RDH12
- TULP1
- SPATA7
- RPE65
- LRAT
- IMPDH1
- OFD1
- ARHGEF18
- CNGA1
- FAM161A
- REEP6
- MERTK
- TOPORS
- AGBL5
- PCARE
- MAK
- NEK2
- PDE6G
- SLC7A14
- NRL
- GUCA1B
- PRCD
- USH2A
- FSCN2
- HGSNAT
- ARL2BP
- PRPF31
- RP9
- TUB
- ZNF513
- IFT88
- CERKL
- RP2
- PRPF4
- AHR
- PDE6A
- RBP3
- CLRN1
- SNRNP200
- RGR
- PRPF8
- CA4
- IDH3B
- CNGB1
- ROM1
- PRPF3
- DHDDS
- RP1
- EYS
- PRPF6
- SCAPER
- KIZ
Clinical Features
Top most frequent phenotypes and symptoms related to Retinitis Pigmentosa
- Intellectual disability
- Nystagmus
- Sensorineural hearing impairment
- Cataract
- Visual impairment
- Hyperreflexia
- Wide nasal bridge
- Optic atrophy
- Anteverted nares
- Blindness
And another 16 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available RETINITIS PIGMENTOSA have a estimated prevalence of 26.7 per 100k in Europe.— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Retinitis Pigmentosa Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
9 %
Genes
70 % |
RPGR Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RPGR
Specificity
100 %
Genes
2 % |
RPGR Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RPGR
Specificity
100 %
Genes
2 % |
RPGR Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
RPGR
Specificity
100 %
Genes
2 % |
RPGR Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RPGR
Specificity
100 %
Genes
2 % |
Cone-Rod Dystrophy Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPGR, CNNM4, SEMA4A, TULP1, CFAP410, BEST1, RPGRIP1, CACNA1F, CDHR1, RIMS1, RAX2, KCNV2, TTLL5, CACNA2D4, PITPNM3, CNGA3, CNGB3, EYS, ADAM9, CERKL , (...)
View the complete list with 16 more genes
Specificity
37 %
Genes
17 % |
Macular Degeneration Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPGR, TIMP3, BEST1, C1QTNF5, ELOVL4, RP1L1, CDH3, RAX2, IMPG2, HMCN1, CNGB3, CTNNA1, MFSD8, DRAM2, EFEMP1, ABCA4, FBLN5, FSCN2, GUCA1B, IMPG1 , (...)
View the complete list with 4 more genes
Specificity
34 %
Genes
11 % |
Comprehensive Pulmonary Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2 , (...)
View the complete list with 73 more genes
Specificity
3 %
Genes
3 % |
You can get up to 1473 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like LUSCAN-LUMISH SYNDROME; LLS PEELING SKIN SYNDROME 5; PSS5 MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA CHROMOSOME 1p36 DELETION SYNDROME CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR